SANGAMO THERAPEUTICS, INC Business Finance Contracts & Agreements
32 Contracts & Agreements
- Funding Agreements (1 contract)
- Guarantee Agreements (1)
- Purchase Agreements (2)
- Share Agreements (2)
- Stock Agreements (17)
- Subscription Agreements (1)
- Underwriting Agreements (6)
- Warrant Agreements (2)
- Form of Securities Purchase Agreement, dated March 21, 2024 by and among Sangamo Therapeutics, Inc. and the purchasers party thereto (Filed With SEC on March 25, 2024)
- Form of Warrant to Purchase Common Stock (Filed With SEC on March 25, 2024)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on March 25, 2024)
- Description of Capital Stock (Filed With SEC on March 13, 2024)
- Stock Purchase Agreement between the Company and Biogen MA, Inc., dated February 26, 2020 (Filed With SEC on May 11, 2020)
- Underwriting Agreement, dated April 4, 2019, by and between Sangamo Therapeutics, Inc. and Cowen and Company, LLC, Wells Fargo Securities, LLC and Barclays Capital Inc., as... (Filed With SEC on April 4, 2019)
- Form of Restricted Stock Unit Grant Notice and Form of Restricted Stock Unit Award Agreement (French employees) under the 2018 Plan and the French RSU Sub-Plan (Filed With SEC on March 1, 2019)
- Form of Stock Option Agreement (French Employees) under the 2018 Plan and the French Options Sub-Plan (Filed With SEC on March 1, 2019)
- Form of Stock Option Grant Notice (French employees) under the 2018 Plan and the French Options Sub-Plan (Filed With SEC on March 1, 2019)
- Amendment Agreement to the Share Purchase Agreement dated October 1, 2018, among the Company and the Sellers (Filed With SEC on November 6, 2018)
- Share Purchase Agreement dated July 20, 2018, among the Company and the Sellers (Filed With SEC on July 23, 2018)
- Underwriting Agreement, dated April 25, 2018, by and between Sangamo Therapeutics, Inc. and Merrill Lynch Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Cowen... (Filed With SEC on April 26, 2018)
- Form of Restricted Stock Unit Award Agreement under the 2013 Plan (Filed With SEC on March 1, 2018)
- 10,000,000 Shares SANGAMO THERAPEUTICS, INC. Common Stock, $0.01 par value UNDERWRITING AGREEMENT (Filed With SEC on June 21, 2017)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (Filed With SEC on January 6, 2017)
- SANGAMO BIOSCIENCES, INC. 4,444,444 Shares of Common Stock par value $0.01 UnderwritingAgreement (Filed With SEC on March 25, 2014)
- 6,100,000 Shares of Common Stock par value $0.001 915,000 Over-Allotment Shares Sangamo BioSciences, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 18, 2013)
- SANGAMO BIOSCIENCES, INC. AUTOMATIC STOCK OPTION AGREEMENT (Filed With SEC on June 14, 2013)
- SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF NON-EMPLOYEE DIRECTOR AUTOMATIC STOCK OPTION (Filed With SEC on June 14, 2013)
- SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF NON-EMPLOYEE DIRECTOR AUTOMATIC STOCK OPTION (Filed With SEC on June 14, 2013)
- SANGAMO BIOSCIENCES, INC. STOCK OPTION AGREEMENT (Filed With SEC on June 14, 2013)
- SANGAMO BIOSCIENCES, INC. NOTICE OF GRANT OF STOCK OPTION (Filed With SEC on June 14, 2013)
- SANGAMO BIOSCIENCES, INC. RESTRICTED STOCK UNIT ISSUANCE AGREEMENT (Filed With SEC on June 14, 2013)
- 6,700,000 Shares Sangamo BioSciences, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 11, 2011)
- 3,000,000 Shares Sangamo Biosciences, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 13, 2009)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 5, 2009)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 10, 2007)
- Asset Purchase Agreement (Filed With SEC on December 28, 2006)
- 3,100,000 Shares SANGAMO BIOSCIENCES, INC. Common Stock PURCHASE AGREEMENT (Filed With SEC on June 16, 2006)
- SUBSCRIPTION AGREEMENT (Filed With SEC on November 14, 2005)
- 5,080,000 Shares SANGAMO BIOSCIENCES, INC. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on November 14, 2005)
- FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENT (Filed With SEC on March 27, 2003)
